Document is current
Any future updates will be listed below
-
Authors
Kang, Liuyang https://orcid.org/0009-0004-2041-8508
Wei, Mingwei
Jiang, Hui
Zang, Xia
Pan, Yu
An, Youcai
Yang, Jing
Tian, Siyu
Tao, Hang
Pan, Hongxing
Jin, Hui
-
Funding
Funding for this research was provided by:
Center for Drug Reevaluation, NMPA (CDRZ20234001-2)
- License Information
-
More Information
Article History
Received: 20 July 2026
Accepted: 26 August 2026
First Online: 11 September 2026
Declarations
Conflict of interest: All authors have declared no conflicts of interest. Mingwei Wei, Hui Jiang, Xia Zang, Yu Pan, Hongxing Pan, and Hui Jin have nothing to disclose. Youcai An, Jing Yang, Siyu Tian, Liuyang Kang, and Hang Tao are employees of Ab&B Biotech Co., Ltd.
Ethical Approval: This study adheres to the ethical principles for medical research involving human participants as outlined in the Declaration of Helsinki. This study was reviewed and approved by the Ethics Committee of Jiangsu Provincial Center for Disease Control and Prevention (approval number JSJK2023-B016-02). The study was registered in the Drug Clinical Trial Registration and Information Disclosure Platform of China ( ) with registration number CTR20244333, and in ClinicalTrials.gov with registration number NCT07710586.
